| | |  | | | | Record from Web of Science® | | | | | | |
| Regulation of financial conflicts of interest in medical practice and medical research - a damaging solution in search of a problem |
|
|
| Author(s): Stossel TP (Stossel, Thomas P.) |
| Source: PERSPECTIVES IN BIOLOGY AND MEDICINE Volume: 50 Issue: 1 Pages: 54-71 Published: WIN 2007 |
| Times Cited: 14 References: 45 |
| Abstract: The free market, which includes most practicing physicians, publicly supported biomedical researchers, and private drug and device companies, has succeeded spectacularly in delivering new medical technologies to the public. Increased interactions between doctors (physicians and biomedical researchers), epitomized by the founding of the biotechnology revolution, have and can continue to accelerate this delivery. A powerful anti-commercial advocacy movement that has blossomed over the past 20 years threatens this momentum. This movement has succeeded in inverting reality by demonizing the market and by promoting distorted and damaging views of professionalism and of science. Most ominously, it has imposed onerous and counterproductive regulations on medical education and translational research. |
| Document Type: Article |
| Language: English |
| Reprint Address: Stossel, TP (reprint author), Brigham & Womens Hosp, Translat Med Div, 1 Blackfan Circle,Karp 6, Boston, MA 02115 USA |
Addresses:
1. Brigham & Womens Hosp, Translat Med Div, Boston, MA 02115 USA
2. Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA |
| Publisher: JOHNS HOPKINS UNIV PRESS, JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA |
| Subject Category: History & Philosophy Of Science; Medicine, Research & Experimental |
| IDS Number: 129OB |
| ISSN: 0031-5982 |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |